Albert Labs International Corp.
Albert Labs International Corp.
Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.
Albert Labs International Corp. (ABRT)
SEDAR Information
Company Info
Capitalization
News Releases
Albert Labs Granted MCTO
Albert Labs Announces New Director
Bulletins
2024-0717 - Suspensions - ABRT, JUVA, LITE, VSBY, VSBY.WT.B
le 16 juillet/July 2024
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
